COVID-19-Impfung unter PsychopharmakotherapieArticle Published on 2021-11-032023-06-16 Journal: Psychiatrische Praxis [Category] MERS, SARS, [키워드] Antidepressant drugs Antidepressiva Antipsychotic drugs Antipsychotika COVID-19 Impfungen psychiatric patients psychiatrische Patienten Vaccines [DOI] 10.1055/a-1531-4460 PMC 바로가기
Drug repurposing of selective serotonin reuptake inhibitors: Could these drugs help fight COVID-19 and save lives?선택적 세로토닌 재흡수 억제제의 약물 용도 변경: 이 약물이 COVID-19와 싸우고 생명을 구하는 데 도움이 될 수 있습니까?Review Published on 2021-06-012022-08-31 Journal: Journal of clinical neuroscience : official journa [Category] MERS, 신약개발, 치료제, [키워드] 2019 novel coronavirus absence Affect Anti-inflammatory antidepressant Antidepressant drugs antiviral properties attenuate CCL-2 class clinical trials confirmed case coronavirus disease COVID-19 COVID-19 patients curative treatment Cytokines death disease drug Drug repurposing effective Emerging infectious disease Evidence Fluoxetine focus help identify IL-6 immune system immunomodulatory Infectious disease life management mental health morbidity Neurological complication Neurological complications Novel coronavirus novel coronavirus disease pandemic present pro-inflammatory Quality of life reduce reducing reported Safe SARS-CoV-2 selective Selective serotonin reuptake inhibitors (SSRIs). Serotonin serotonin reuptake inhibitor serotonin reuptake inhibitors tested therapeutic therapeutic agent therapeutic strategy TNF-α Tolerability Vaccine widespread [DOI] 10.1016/j.jocn.2021.03.010 PMC 바로가기 [Article Type] Review